Prescription Drug Affordability Boards (PDABs) and Upper Payment Limits (UPLs) Impact on Patients, Drug Pricing, and Innovation
April 4, 2024This HealthHIV Advocacy paper explores the function of Prescription Drug Affordability Boards (PDABs) in managing prescription drug costs, considering perspectives of patients, providers, and payers to ensure equitable access to vital medications while controlling healthcare expenses.
Aging with Pride: National Health, Aging, and Sexuality/Gender Study
February 5, 2024This landmark study is the first federally-funded longitudinal national project designed to better understand the aging, health, and well-being of sexual and gender diverse midlife and older adults.
Integrating Frailty and Functional Outcomes into Clinical Trials
Considerations of frailty and functional outcomes for better integration and representation of aging patients in clinical trials.
Inflamm-aging: Effects of Chronic Inflammation with HIV
Advances in Antiretroviral therapy (ART) allow people with HIV to live longer with fewer medications. Join us as Dr. Peter Hunt details the connection between chronic inflammation and HIV infection and discusses care considerations and emerging research.
Understanding and sharing your HIV status stories
April 8, 2023Hear from people with HIV about how they learned that they had HIV, how they felt, and how they decided to share their status with other people.
The Importance of Synchronicity for Remedying Health Inequities
September 30, 2021At SYNC 2021, our nation’s public health leaders, service providers, and community organizers spoke on the various ways in which different sectors of society can come together to end the epidemics that impact underserved communities.
True Stories: Living with HIV
November 10, 2020These are the stories of three people who are using their experiences of living with HIV to encourage people to get tested, share their stories, or find out what options are best for them.
A continuum of HIV care describing mortality and loss to follow-up: a longitudinal cohort study
June 4, 2018A cross-sectional study assessed how effective it was for those on HIV meds to not transmit to others, along with how high the loss to follow-up was in various HIV programs. They found that there was a high loss of follow-up in HIV care programs, but it highlighted the need for intervention as well as an increase in rates of viral suppression.
